Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Estetrol helps keep scalp hair in the growth phase longer and improves hair follicle health by affecting the hair root and increasing stem cells.

The treatment slightly increased hair growth and was safe for most women.

Cyproterone helps women with hair loss caused by genetics. More research is needed to confirm the best dose.

No significant link was found between the studied genes and female hair loss in the Polish population.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Finasteride's molecular properties and active sites were identified using computational methods.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Rodent models of PCOS show some similar and some different lipid changes compared to humans.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Applying estradiol to skin causes local changes but not cancer.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.